Complement Factor H - LFB
Alternative Names: Factor H; fHLatest Information Update: 02 Oct 2021
At a glance
- Originator LFB
- Class Beta-globulins; Biological proteins; Complement C3b inactivator proteins
- Mechanism of Action Complement system protein replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemolytic uraemic syndrome
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Haemolytic-uraemic-syndrome in France (Parenteral)
- 31 Dec 2009 Preclinical trials in Haemolytic uraemic syndrome in France (Parenteral)
- 07 Dec 2009 Complement Factor H - LFB receives Orphan Drug status for Haemolytic uraemic syndrome in USA